Akanda announces closing of registered direct offering priced at-the-market under nasdaq rules

London, united kingdom--(newsfile corp. - february 2, 2024) - akanda corp. (nasdaq: akan) ("akanda" or the "company"), an international medical cannabis company, today announced that it has closed its previously announced registered direct offering for the sale and issuance of 280,851 common shares at a purchase price of $0.406 per share, and pre-funded warrants to purchase 1,462,991 common shares at a price of $0.4059 per share, priced at-the-market under the nasdaq rules. the pre-funded warrants are immediately exercisable for $0.0001 per share and may be exercised at any time until all of the pre-funded warrants are exercised in full, subject to certain beneficial ownership limitations as set forth in the pre-funded warrant.
AKAN Ratings Summary
AKAN Quant Ranking